These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2930064)
1. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains. Tsukamura M; Miyachi T Am Rev Respir Dis; 1989 Apr; 139(4):1033-5. PubMed ID: 2930064 [TBL] [Abstract][Full Text] [Related]
2. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex]. Tsukamura M Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652 [TBL] [Abstract][Full Text] [Related]
3. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex. Tsukamura M Am Rev Respir Dis; 1988 Jan; 137(1):144-8. PubMed ID: 3337455 [TBL] [Abstract][Full Text] [Related]
4. [Correlation of minimal inhibitory concentration values of antituberculosis agents against Mycobacterium avium complex strains with incubation period]. Tsukamura M; Ichiyama S Kekkaku; 1988 Feb; 63(2):107-10. PubMed ID: 3373933 [No Abstract] [Full Text] [Related]
5. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs]. Tomioka H; Sato K; Saito H Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791 [TBL] [Abstract][Full Text] [Related]
6. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program]. Popov SA; Dorozhkova IR; Medvedeva IM Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457 [TBL] [Abstract][Full Text] [Related]
7. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains]. Tsukamura M Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312 [No Abstract] [Full Text] [Related]
8. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Zimmer BL; DeYoung DR; Roberts GD Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626 [TBL] [Abstract][Full Text] [Related]
9. Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare. Renvoisé A; Bernard C; Veziris N; Galati E; Jarlier V; Robert J J Clin Microbiol; 2014 Dec; 52(12):4439-40. PubMed ID: 25274991 [No Abstract] [Full Text] [Related]
10. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis. Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria. Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398 [TBL] [Abstract][Full Text] [Related]
12. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents. Kamal A; Hari Babu A; Venkata Ramana A; Sinha R; Yadav JS; Arora SK Bioorg Med Chem Lett; 2005 Apr; 15(7):1923-6. PubMed ID: 15780634 [TBL] [Abstract][Full Text] [Related]
13. [The pattern of development of resistance to antituberculosis agents in mycobacterium avium complex]. Tsukamura M Kekkaku; 1987 Sep; 62(9):445-58. PubMed ID: 3430947 [No Abstract] [Full Text] [Related]
14. Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates. Vanitha JD; Paramasivan CN Diagn Microbiol Infect Dis; 2004 Jul; 49(3):179-82. PubMed ID: 15246507 [TBL] [Abstract][Full Text] [Related]
15. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex]. Tsukamura M Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509 [TBL] [Abstract][Full Text] [Related]
16. [Radiometric determination of Mycobacterium avium-intracellulare and Mycobacterium xenopi sensitivity to antitubercular agents]. Kubín M; Lindholm-Levy P; Heifets LB Epidemiol Mikrobiol Imunol; 1994 Sep; 43(3):104-6. PubMed ID: 7953081 [TBL] [Abstract][Full Text] [Related]
17. The absence of genetic markers for streptomycin and rifampicin resistance in Mycobacterium avium complex strains. Portillo-Gomez L; Nair J; Rouse DA; Morris SL J Antimicrob Chemother; 1995 Dec; 36(6):1049-53. PubMed ID: 8821605 [TBL] [Abstract][Full Text] [Related]
18. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium]. Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between the susceptibility testing of Mycobacterium avium complex strains and the clinical efficacy of antituberculosis drugs--an evidence suggesting that antituberculosis drugs are effective in the treatment of M. avium complex pulmonary infection]. Tsukamura M; Ichiyama S; Miyachi T Kekkaku; 1988 Apr; 63(4):227-31. PubMed ID: 3404801 [No Abstract] [Full Text] [Related] [Next] [New Search]